Dr Carrie van der Weyden
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
26 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
On the RAdR in relapsed T-cell lymphoma
DOI: 10.1182/bloodadvances.20260199252026
Journal article
Radiotherapy dose–response of mycosis fungoides with large cell transformation
DOI: 10.1016/j.radonc.2025.1112922026
Journal article
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options
DOI: 10.1080/10428194.2025.25986622026
Journal article
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium
DOI: 10.1080/10428194.2026.26299532025
Conference Proceedings
Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
DOI: 10.1182/blood-2025-41122025
Journal article
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
DOI: 10.3390/jpm151105602025
Journal article
Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes
DOI: 10.1111/bjh.20225
RECENT SCHOLARLY WORKS
2025
Journal article
Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study
DOI: 10.1111/bjh.200632025
Journal article
Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study.
DOI: 10.1002/jha2.700332025
Journal article
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
DOI: 10.1182/bloodadvances.2024014674